23 Stocks Moving in Thursday's Pre-Market Session

Gainers

  • Kaival Brands Innovations Group, Inc. KAVL rose 54.3% to $0.9490 in pre-market trading after declining more than 11% on Wednesday.
  • Alterity Therapeutics Limited ATHE rose 35.1% to $1.12 in pre-market trading after the company said it was granted new US patent for compounds for neurodegenerative diseases including Parkinson's and Alzheimer's.
  • Siyata Mobile Inc. SYTA rose 10.6% to $3.55 in pre-market trading after declining over 9% on Wednesday.
  • Spruce Biosciences, Inc. SPRB rose 9.6% to $3.90 in pre-market trading after dropping over 15% on Wednesday. The company yesterday named Dr. Javier Szwarcberg, M.D., MPH, as Chief Executive Officer and as a member of the board of directors.
  • TherapeuticsMD, Inc. TXMD rose 9.1% to $0.4380 in pre-market trading. TherapeuticsMD recently announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women with vasomotor symptoms due to menopause.
  • Camber Energy, Inc. CEI rose 8.6% to $0.9120 in pre-market trading after declining around 8% on Wednesday. The company recently closed $25 million transaction with institutional investor.
  • Largo Inc. LGO rose 5.9% to $10.81 in pre-market trading after gaining more than 3% on Wednesday.
  • ObsEva SA OBSV rose 5.8% to $2.18 in pre-market trading after the company reported topline results for Linzagolix 200 mg with add-back therapy in the Phase 3 EDELWEISS 3 trial in patients with moderate-to-severe endometriosis-associated pain.
  • Murphy Oil Corporation MUR rose 5.4% to $30.75 in pre-market trading. Murphy Oil is expected to report Q4 results on Thursday, January 27, 2022.
  • Deutsche Bank Aktiengesellschaft DB rose 5% to $13.83 in pre-market trading.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Berkeley Lights, Inc. BLI fell 28.3% to $11.67 in pre-market trading after the company issued weak sales forecast for FY21. The company said it sees FY21 sales of $84 million to $84.5 million, versus analysts’ estimates of $90.9 million and also projects FY22 sales growth of 30% year over year. The company’s CEO Eric D. Hobbs will transition to president of Antibody Therapeutics Line.
  • CNS Pharmaceuticals, Inc. CNSP shares fell 14% to $0.9030 in pre-market trading after jumping over 31% on Wednesday.
  • MicroVision, Inc. MVIS shares fell 11.9% to $4.35 in pre-market trading after dropping more than 12% on Wednesday.
  • ATA Creativity Global AACG fell 11.3% to $2.04 in pre-market trading after dropping around 10% on Wednesday.
  • NLS Pharmaceutics AG NLSP fell 9.9% to $1.37 in pre-market trading. The company recently announced the USPTO granted the company U.S. Patent No. 11207271, entitled A Mazindol Ir/Sr Multilayer Tablet And Its Use For The Treatment Of Attention Deficit/Hyperactivity Disorder.
  • Ebang International Holdings Inc. EBON shares fell 9.7% to $1.03 in pre-market trading after gaining around 10% on Wednesday.
  • Vertical Aerospace Ltd. EVTL fell 9.4% to $8.20 in pre-market trading after jumping more than 29% on NASDAQ.
  • Lixte Biotechnology Holdings, Inc. LIXT shares fell 7.2% to $2.05 in pre-market trading. Lixte Biotech shares jumped around 64% on Wednesday after the company announced that in preclinical studies its lead clinical compound, LB-100, a protein phosphatase inhibitor, was found to increase the responsiveness of diverse cancers to immunotherapy.
  • Oncternal Therapeutics, Inc. ONCT fell 7% to $2.12 in pre-market trading. Oncternal Therapeutics recently announced consensus with the FDA on the Phase 3 registrational study design for zilovertamab in treatment of mantle cell lymphoma.
  • Plus Therapeutics, Inc. PSTV shares fell 7% to $1.20 in pre-market trading. Plus Therapeutics recently announced it has met two significant milestones as it progresses toward cGMP manufacture of Rhenium-186 NanoLiposome.
  • Hoth Therapeutics, Inc. HOTH shares fell 6.9% to $1.08 in pre-market trading. Hoth Therapeutics recently announced proof-of-concept data generated using an Alzheimer's disease mouse model, supporting the therapeutic potential of HT-ALZ.
  • Data Storage Corporation DTST shares fell 5.8% to $3.89 in pre-market trading. Data Storage shares climbed more than 33% on Wednesday after the company announced a multi-million dollar contract with a professional sports team.
  • Connect Biopharma Holdings Limited CNTB fell 5.6% to $4.72 in pre-market trading. Connect Biopharma recently reported detailed dataset from global Phase 2b trial of CBP-201 in adult patients with moderate-to-severe atopic dermatitis.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!